NucleaRDB: Extraction of mutation data from the literature

logo    2005, NucleaRDB.


This data was extracted from Medline abstracts and full texts (when available) in an automated manner.

The table below describes the selected point mutation and provides links to other documents. The sentence(s) where the point mutation S112A was found are listed after the table.

The mutated residues are also indicated in the family sequence alignments and hyperlinked to the corresponding mutation pages.


Point mutation S112A in PPAT_HUMAN

Point mutation:S112A
Domain:N-term
General numbering (NucleaRDB): -
Protein:PPAT_HUMAN (PPARG,NR1C)Swiss-Prot
Cross-reference table
Family page
Protein isoforms2
Other point mutations / same proteinList of mutations in PPAT_HUMAN
Family alignments 1C3 PPAR gamma
1C Peroxisome proliferator activated (PPAR)
1 Thyroid hormone like (TR,RAR,ROR,PPAR,VDR
Other point mutations / same position Position 82 in 1C3 PPAR gamma family
Position 76 in 1C Peroxisome proliferator activated (PPAR) family
Position 26 in 1 Thyroid hormone like (TR,RAR,ROR,PPAR,VDR family
Reference:Pioglitazone ameliorates tumor necrosis factor-alpha-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator--activated receptor-gamma.
Iwata M, Haruta T, Usui I, Takata Y, Takano A, Uno T, Kawahara J, Ueno E, Sasaoka T, Ishibashi O, Kobayashi M
Diabetes 2001 May;50(5):1083-92.
Medline
Other point mutations / same articleList
Text sourceHTML and PDF full texts
Validation statusTrue positive

Relevant sentences:

S112A


Button bar
F.Horn (nucleardbcmbi.kun.nl), 21-Apr-2005